Back

Effect of anticoagulation on mortality by CHADSVASC score in patients with atrial fibrillation: comparison to patients without atrial fibrillation

28 August 2018 (10:05 - 10:55)
Organised by:
Congress Presentation Part of: Atrial fibrillation - Anticoagulation Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Serge Harb

Cleveland Clinic, Cleveland (United States of America)

6 More presentations in this session

Presentation thumbnail
NOACs versus warfarin in atrial fibrillation patients and risk of dementia: a nationwide propensity-weighted cohort study
Mrs M. Soegaard (Aalborg, DK)
Abstract Slides
Presentation thumbnail
Resuming anticoagulation in patients with atrial fibrillation experiencing hemorrhage stroke or nontraumatic intracranial hemorrhage
Assistant Professor V. Wu (Tao-Yuan, TW)
Abstract Slides
Presentation thumbnail
Identification of atrial fibrillation patients who are at high bleeding risk after undergoing percutaneous coronary intervention: insights from the PIONEER AF-PCI trial
Doctor T. Nafee (Boston, US)
Abstract Slides
Presentation thumbnail
Geographic region, stroke risk and renal function strongly affect treatment choice for stroke prevention in patients with non-valvular AF: results from the GLORIA-AF registry program
Doctor L. Riou Franca (Ingelheim, DE)
Abstract
Presentation thumbnail
Thrombosis of left atrial appendage closure devices - What is the clinical impact?
Doctor V. Lekesova (Prague, CZ)
Abstract Slides

Access the full session

Session thumbnail
Atrial fibrillation - Anticoagulation

The Event

Event poster

ESC Congress 2018

28 August 2018 10:05 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources